India’s listed hospitals are likely to maintain double-digit revenue growth even as EBITDA margins stay rangebound due to a hectic bed-addition cycle, brokerage firm Kotak Securities said in a research report.
India’s listed hospitals are likely to maintain double-digit revenue growth even as EBITDA margins stay rangebound due to a hectic bed-addition cycle, brokerage firm Kotak Securities said in a research report.